Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

[Ziconotide: an innovative alternative for intense chronic neuropathic pain.]

[Ziconotide: an innovative alternative for intense chronic neuropathic pain.] Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • [Ziconotide: an innovative alternative for intense chronic neuropathic pain.] Abstract Text:

    j c valia-veraJ C Valia-Vera,v l villanuevaV L Villanueva,j m asensio-samperJ M Asensio-Samper,m d lopez-alarconM D Lopez-Alarcon,j a de andresJ A de Andres,j c J C ,v l villanuevaV L Villanueva,j m asensio-samperJ M Asensio-Samper,m d M D ,j a J A ,j c valía-veraJ C Valía-Vera,v l villanuevaV L Villanueva,j m asensio-samperJ M Asensio-Samper,m d lópez-alarcónM D López-Alarcón,j a de andrésJ A de Andrés,

    INTRODUCTION. Intense chronic pain is a very important health problem, as it has a high prevalence (5-10%), a multifactorial aetiology and its management is very often a very complex affair. Treatment of severe cases sometimes requires interventional approaches, such as continuous intrathecal infusion of opioids. CASE REPORT. We report the case of a 38-year-old female with intense neuropathic pain in the lower back and the lower limbs secondary to three operations on the L5-S1 lumbar segment. After implementing several different pharmacological regimes involving both oral and implanted systems (spinal cord stimulation and subarachnoid infusion pump with different pharmacological combinations) with no clinical improvement, intrathecal infusion with ziconotide was included in the protocol. CONCLUSIONS. Ziconotide is the first specific neuronal blocker that acts on the calcium channel by blocking the N-type voltage-dependent calcium channels. It is a new non-opioid analgesic with approved indication in the treatment of intense chronic pain, in patients who require intrathecal analgesics and are refractory to other analgesic treatments. Therefore, we shall have to consider this drug as a therapeutic alternative in patients do not experience sufficient relief with the pharmacological agents and means currently available to treat them.

    [Ziconotide: an innovative alternative for intense chronic neuropathic pain.] Publishing Authors By Initials

    jc valia-veraJC Valia-Vera,vl villanuevaVL Villanueva,jm asensio-samperJM Asensio-Samper,md lopez-alarconMD Lopez-Alarcon,ja de andresJA de Andres,jc JC ,vl villanuevaVL Villanueva,jm asensio-samperJM Asensio-Samper,md MD ,ja JA ,jc valía-veraJC Valía-Vera,vl villanuevaVL Villanueva,jm asensio-samperJM Asensio-Samper,md lópez-alarcónMD López-Alarcón,ja de andrésJA de Andrés,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    [Ziconotide: an innovative alternative for intense chronic neuropathic pain.] Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Revista de neurologia

    VOLUME: 45

    Page Numbers: 665-9

    Journal Abbreviation:

    ISSN: 0210-0010

    DAY: 30

    MONTH: 11

    YEAR: 2007

    [Ziconotide: an innovative alternative for intense chronic neuropathic pain.] Information

    Number of References:

    LANGUAGE: spa

    NlmUniqueID: 7706841

    [Ziconotide: an innovative alternative for intense chronic neuropathic pain.] Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: [Ziconotide: an innovative alternative for intense chronic neuropathic pain.] Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for [Ziconotide: an innovative alternative for intense chronic neuropathic pain.]

    AFFILIATION: Consorcio Hospital General Universitario de Valencia, Valencia, Espana.

    Country: Spain

    Spain Research PublicationSpain Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Rev Neurol

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Ziconotide: an innovative alternative for intense chronic neuropathic pain Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News